-
Je něco špatně v tomto záznamu ?
Epidemiology of rare diseases detected by newborn screening in the Czech Republic
Jan David, Petr Chrastina, Karolina Pešková, Viktor Kožich, David Friedecký, Tomáš Adam, Eva Hlídková, Hana Vinohradská, Dana Novotná, Monika Hedelová, Eva Al Taji, Andrea Holubová, Veronika Skalická, Milan Macek, Renata Gaillyová, Felix Votava
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Digitální knihovna NLK
Zdroj
NLK
Free Medical Journals
od 2004
ProQuest Central
od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost)
od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest)
od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest)
od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources
od 1993
PubMed
31241292
DOI
10.21101/cejph.a5441
Knihovny.cz E-zdroje
- MeSH
- biologické markery krev MeSH
- fluorometrie MeSH
- lidé MeSH
- novorozenec MeSH
- novorozenecký screening metody MeSH
- tandemová hmotnostní spektrometrie MeSH
- vzácné nemoci krev epidemiologie MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
OBJECTIVES: Presymptomatic detection of patients with rare diseases (RD), defined by a population frequency less than 1 : 2,000, is the task of newborn screening (NBS). In the Czech Republic (CZ), currently eighteen RD are screened: phenylketonuria/hyperphenylalaninemia (PKU/HPA), congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH), cystic fibrosis (CF), medium chain acyl-CoA dehydrogenase deficiency (MCADD), long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD), very long chain acyl-CoA dehydrogenase deficiency (VLCADD), carnitine palmitoyl transferase I and II deficiency (CPTID, CPTIID), carnitine-acylcarnitine translocase deficiency (CACTD), maple syrup urine disease (MSUD), glutaric aciduria type I (GA I), isovaleryl-CoA dehydrogenase deficiency (IVA), argininemia (ARG), citrullinemia (CIT), biotinidase deficiency (BTD), cystathionine beta-synthase-deficient homocystinuria (CBSD HCU), and methylenetetrahydrofolate reductase deficiency homocystinuria (MTHFRD HCU). The aim was to analyze the prevalence of RD screened by NBS in CZ. METHODS: We examined the NBS programme in CZ from 1 January 2010 to 31 December 2017, which covered 888,891 neonates. Dried blood spots were primarily analyzed using fluorescence immuno-assay, tandem mass spectrometry and fluorimetry. RESULTS: The overall prevalence of RD among the neonate cohort was 1 : 1,043. Individually, 1 : 2,877 for CH, 1 : 5,521 for PKU/HPA, 1 : 6,536 for CF (1 : 5,887 including false negative patients), 1 : 12,520 for CAH, 1 : 22,222 for MCADD, 1 : 80,808 for LCHADD, 1 : 177,778 for GA I, 1 : 177,778 for IVA, 1 : 222,223 for VLCADD, 1 : 296,297 for MSUD, 1 : 8,638 for BTD, and 1 : 181,396 for CBSD HCU. CONCLUSIONS: The observed prevalence of RD, based on NBS, corresponds to that expected, more precisely it was higher for BTD and lower for MSUD, IVA, CBSD HCU, MCADD and VLCADD. Early detection of rare diseases by means of NBS is an effective secondary prevention tool.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19024831
- 003
- CZ-PrNML
- 005
- 20190801103616.0
- 007
- ta
- 008
- 190704s2019 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a5441 $2 doi
- 035 __
- $a (PubMed)31241292
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a David, Jan $u Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague; Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $7 xx0224671
- 245 10
- $a Epidemiology of rare diseases detected by newborn screening in the Czech Republic / $c Jan David, Petr Chrastina, Karolina Pešková, Viktor Kožich, David Friedecký, Tomáš Adam, Eva Hlídková, Hana Vinohradská, Dana Novotná, Monika Hedelová, Eva Al Taji, Andrea Holubová, Veronika Skalická, Milan Macek, Renata Gaillyová, Felix Votava
- 520 9_
- $a OBJECTIVES: Presymptomatic detection of patients with rare diseases (RD), defined by a population frequency less than 1 : 2,000, is the task of newborn screening (NBS). In the Czech Republic (CZ), currently eighteen RD are screened: phenylketonuria/hyperphenylalaninemia (PKU/HPA), congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH), cystic fibrosis (CF), medium chain acyl-CoA dehydrogenase deficiency (MCADD), long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD), very long chain acyl-CoA dehydrogenase deficiency (VLCADD), carnitine palmitoyl transferase I and II deficiency (CPTID, CPTIID), carnitine-acylcarnitine translocase deficiency (CACTD), maple syrup urine disease (MSUD), glutaric aciduria type I (GA I), isovaleryl-CoA dehydrogenase deficiency (IVA), argininemia (ARG), citrullinemia (CIT), biotinidase deficiency (BTD), cystathionine beta-synthase-deficient homocystinuria (CBSD HCU), and methylenetetrahydrofolate reductase deficiency homocystinuria (MTHFRD HCU). The aim was to analyze the prevalence of RD screened by NBS in CZ. METHODS: We examined the NBS programme in CZ from 1 January 2010 to 31 December 2017, which covered 888,891 neonates. Dried blood spots were primarily analyzed using fluorescence immuno-assay, tandem mass spectrometry and fluorimetry. RESULTS: The overall prevalence of RD among the neonate cohort was 1 : 1,043. Individually, 1 : 2,877 for CH, 1 : 5,521 for PKU/HPA, 1 : 6,536 for CF (1 : 5,887 including false negative patients), 1 : 12,520 for CAH, 1 : 22,222 for MCADD, 1 : 80,808 for LCHADD, 1 : 177,778 for GA I, 1 : 177,778 for IVA, 1 : 222,223 for VLCADD, 1 : 296,297 for MSUD, 1 : 8,638 for BTD, and 1 : 181,396 for CBSD HCU. CONCLUSIONS: The observed prevalence of RD, based on NBS, corresponds to that expected, more precisely it was higher for BTD and lower for MSUD, IVA, CBSD HCU, MCADD and VLCADD. Early detection of rare diseases by means of NBS is an effective secondary prevention tool.
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a fluorometrie $7 D005470
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a novorozenecký screening $x metody $7 D015997
- 650 _2
- $a vzácné nemoci $x krev $x epidemiologie $7 D035583
- 650 _2
- $a tandemová hmotnostní spektrometrie $7 D053719
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chrastina, Petr $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $7 xx0082034
- 700 1_
- $a Pešková, Karolína $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $7 xx0172216
- 700 1_
- $a Kožich, Viktor, $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $d 1960- $7 jo2003181496
- 700 1_
- $a Friedecký, David $u Department of Clinical Biochemistry, Faculty of Medicine, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic $7 xx0142900
- 700 1_
- $a Adam, Tomáš, $u Department of Clinical Biochemistry, Faculty of Medicine, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic $d 1965- $7 xx0054162
- 700 1_
- $a Hlídková, Eva $u Department of Clinical Biochemistry, Faculty of Medicine, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic $7 xx0074044
- 700 1_
- $a Vinohradská, Hana, $u Department of Clinical Biochemistry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $d 1960- $7 xx0224599
- 700 1_
- $a Novotná, Dana, $u Department of Paediatrics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $d 1959- $7 xx0043805
- 700 1_
- $a Hedelová, Monika $u Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $7 xx0224683
- 700 1_
- $a Al Taji, Eva $u Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $7 xx0074352
- 700 1_
- $a Holubová, Andrea $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $7 xx0081942
- 700 1_
- $a Skalická, Veronika $u Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $7 xx0081946
- 700 1_
- $a Macek, Milan, $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $d 1961- $7 mzk2006348713
- 700 1_
- $a Gaillyová, Renata, $u Department of Medical Genetics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $d 1957- $7 jo20010084782
- 700 1_
- $a Votava, Felix, $u Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $d 1957- $7 xx0060357
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 27, č. 2 (2019), s. 153-159
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31241292 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y 4 $z 0
- 990 __
- $a 20190704 $b ABA008
- 991 __
- $a 20190801080023 $b ABA008
- 999 __
- $a ok $b bmc $g 1428376 $s 1063249
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 27 $c 2 $d 153-159 $e - $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
- LZP __
- $b NLK111 $a Pubmed-20190704
